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Abstract
Background: A study in frog and chicken embryos, and reports of a high incidence of birth defects in regions of
intensive GM-soy planting have raised concerns on the teratogenic potential of glyphosate-based herbicides. These
public concerns prompted us to conduct a systematic review of the epidemiological studies testing hypotheses of
associations between glyphosate exposure and adverse pregnancy outcomes including birth defects.
Methods: A systematic and comprehensive literature search was performed in MEDLINE, TOXLINE, Bireme-BVS
and SCOPUS databases using different combinations of exposure and outcome terms. A case–control study on the
association between pesticides and congenital malformations in areas of extensive GM soy crops in South America,
and reports on the occurrence of birth defects in these regions were reviewed as well.
Results: The search found ten studies testing associations between glyphosate and birth defects, abortions, pre-term
deliveries, small for gestational date births, childhood diseases or altered sex ratios. Two additional studies examined
changes of time-to-pregnancy in glyphosate-exposed populations. Except for an excess of Attention Deficit Hyperactivity
Disorder - ADHD (OR = 3.6, 1.3-9.6) among children born to glyphosate appliers, no significant associations between this
herbicide and adverse pregnancy outcomes were described. Evidence that in South American regions of intensive
GM-soy planting incidence of birth defects is high remains elusive.
Conclusions: Current epidemiological evidence, albeit limited to a few studies using non-quantitative and indirect
estimates and dichotomous analysis of exposures, does not lend support to public concerns that glyphosate-based
pesticides might pose developmental risks to the unborn child. Nonetheless, owing to methodological limitations
of existing analytical observational studies, and particularly to a lack of a direct measurement (urine and/or blood
levels), or an indirect estimation of exposure that has proven valid, these negative findings cannot be taken as
definitive evidence that GLY, at current levels of occupational and environmental exposures, brings no risk for
human development and reproduction.
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Background
Glyphosate (N-(phosphonomethyl)glycine, GLY) is a
broad-spectrum herbicide launched onto the market in
1974. It inhibits competitively the enzyme enolpyruvyl-
shikimate phosphate synthase (EPSPS) thereby blocking
the production of chorismate, an intermediate for the
biosynthesis of phenylalanine, tyrosine and tryptophan
[1]. Contrasting to plants, bacteria and fungi, animals do
not have the genes coding for EPSPS and depend on a
dietary source for these essential aromatic amino acids.
Although exhibiting plant- selective toxicity, GLY-based
herbicides might eventually impair human health
through modes of action other than inhibition of a shi-
kimate metabolic pathway [1].
Pre-marketing safety evaluation of GLY and its major
breakdown product AMPA (aminomethylphosphonic
acid) did not reveal substance-related significant health
hazards. Some post-marketing toxicity studies conducted
by academic researchers, however, raised concerns about
possible adverse health consequences of occupational ex-
posures to GLY-based herbicides [2–4]. A methodological
constraint common to many of these non-industry tox-
icity studies is the use of a commercial product (e.g.,
Roundup®) rather than the active ingredient (GLY), and
the lack of adequate controls for the effects of formulation
ingredients other than GLY. Formulated GLY-based herbi-
cides often contain substantial amounts of surfactants
(e.g., polyoxyethyleneamine or POEA) the biological ef-
fects of which may account for product toxicity.
Since the introduction of GLY-resistant genetically
modified (GM) soybean in the 1990s, GLY has become
the most extensively used herbicide in Brazil, USA and
other major soybean production countries. Moreover,
the ADI (Acceptable Daily Intake) for GLY established
by FAO/WHO augmented from 0–0.3 mg/kg bw/d
(1986) to 0–1.0 mg/kg bw/d (2004), while maximum
residue concentrations (MRCs) for GLY in soy and sev-
eral other food crops increased as well [5]. A recent clas-
sification of GLY as “probably carcinogenic to humans”
(group 2A) by the IARC fueled the ongoing debate about
the safety of this herbicide. Classification of GLY into
2A group was based on “limited” evidence in humans
(association with non-Hodgkin lymphomas) and
“sufficient” evidence of carcinogenicity in animals [6].
Because of IARC classification and growing public
concerns on the safety of GLY, the Brazilian regulatory
agency (ANVISA) has scheduled a re-evaluation of
GLY-based herbicides for 2016.
Whether the extensive use of GLY poses a risk to human
reproductive health is a controversial matter as well. Studies
sponsored by pesticide manufacturers revealed no notice-
able adverse effects of GLY on mammalian reproduction
and prenatal development [1]. Nonetheless, in 2010,
Paganelli et al. [4] described a harmful effect of GLY-based
herbicides on the development of frog (Xenopus laevis) and
chicken embryos. According to the authors, the neural crest
was the primary target of GLY and the mode by which GLY
disrupts embryo development would be similar to that of
retinoic acid, a known potent human teratogen [4, 7].
Along the same line, two experimental studies performed
by independent researchers suggested that GLY might im-
pair pre and postnatal development in rats [2, 3]. Dallegrave
et al. [2, 3] reported embryotoxic effects (delayed skeleton
ossification in term fetuses) in the offspring of rats treated
with a GLY-based herbicide during pregnancy, and a de-
creased sperm count in adult rats that had been exposed in
utero and during lactation.
South America rural regions are particularly suitable
for studies of GLY impact on human health. In Brazil,
Paraguay and Argentina, there are large GM-soy crop
areas and extensive use of GLY, while in Colombia and
Equator attempts to eradicate illegal crops of coca and
poppy involved aerial spraying of GLY-based herbicides
[8]. A suspected increase in the incidence of birth de-
fects in South American GM soy-crop areas has been
cited in support to the notion that GLY might be a hu-
man developmental toxicant [4, 7, 9–11]. A putative
teratogenicity of GLY has been often commented in the
literature. Samsel and Seneff [12], for instance, specu-
lated that GLY might play a role in the pathogenesis of
celiac (and gluten intolerance) disease and proposed
that adverse influence of maternal celiac disease and
GLY on prenatal development might share a common
mode of action.
This systematic review was undertaken to evaluate
whether results from the existing epidemiological studies
are consistent with the notion that maternal and/or pa-
ternal exposure to GLY increases the risk of birth de-
fects and/or other adverse pregnancy outcomes.
Methods
Literature sources and search strategy
A search was conducted in MEDLINE, TOXLINE, BI-
REME/BVS (Health Virtual Library-Brasil / “Biblioteca Vir-
tual em Saúde–Brasil”) and SCOPUS electronic databases
to identify studies on human reproductive and/or develop-
mental outcomes and GLY-based pesticide exposures. The
literature search covered time windows between the incep-
tion of the database and May 9th, 2015 (MEDLINE), May
12th, 2015 (BIREME/BVS), May 14th, 2015 (TOXLINE),
and May 15th, 2015 (SCOPUS). The search in BIREME/
BVS database covered articles published in periodicals
indexed in the Latin American and the Caribbean Litera-
ture on Health Sciences or LILACS (“Literatura Latino-
Americana e do Caribe em Ciências da Saúde”). LILACS,
the most comprehensive index of scientific and technical
literature on health of Latin America and the Caribbean, in-
cludes local journals not indexed in the other databases
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searched in this study. There was no restriction regarding
the language of the article.
The search in all four databases combined a specific ex-
posure term and one term related to the health outcomes
of interest in English (i.e., “glyphosate AND develop-
mental toxicity”, “glyphosate AND birth defects”, “gly-
phosate AND congenital anomalies”, “glyphosate AND
embryotoxicity”, “glyphosate AND epidemiology”, “glypho-
sate AND pregnancy”, “glyphosate AND teratogenicity”,
“glyphosate AND reproductive outcomes”, “glyphosate and
abortions”, “glyphosate AND malformations”, glyphosate
AND pregnancy outcomes”, “Round up AND developmen-
tal toxicity”, “Round up AND birth defects”, “Round up
AND congenital anomalies”, “Round up AND embryotoxi-
city”, “Round up AND epidemiology”, “Round up AND
pregnancy”, “Round up AND teratogenicity”, “Round up
AND reproductive outcomes”, “Round up and abortions”,
“Round up AND malformations”, “Round up AND preg-
nancy outcomes”. To ensure the completeness of the
search, the reviewers cross checked reference lists in the se-
lected articles and reviews on this topic to identify by hand
searches any relevant studies that might have been eventu-
ally missed by the electronic search.
Study selection and data extraction
To be included in the review an observational study had
to investigate whether paternal and/or maternal exposures
to GLY before conception and/or during pregnancy in-
creased risks of adverse pregnancy outcomes, childhood
health disorders and/or changes in fecundability. Pre-
determined study criteria for exclusion were as follows: 1)
in vitro experimental studies, 2) in vivo and ex vivo studies
in animals, 2) studies of effects on non-target species
other than humans, 3) studies in the area of pesticide
chemistry and agricultural sciences, 4) report of clinical
cases, series of cases, and treatment of intoxications, 5)
studies of associations of postnatal exposures with non-
developmental and/or non-reproductive health outcomes,
6) letters, reviews, editorials, reports, comments, docu-
ments issued by regulatory bodies, and book chapters.
The selection of studies for reviewing involved a two-
phase screening process: at first publications were
screened by titles and abstracts, and if deemed poten-
tially relevant, at a subsequent phase, full text articles
were retrieved. Screening of records for study eligibility
was conducted independently by two reviewers (JAA
and FJRP). If a disagreement persisted after being exten-
sively discussed by the two reviewers, a third investigator
(IFD) was asked to resolve it. For the qualitative synthe-
sis the following data were extracted from the selected
articles: study type, the studied population, its size, loca-
tion and time, how exposure to GLY was assessed, the
adverse outcome of pregnancy and/or the reproductive
outcome evaluated, whether or not the outcome was
significantly associated with GLY, and the strength of as-
sociation (e.g. OR) if available.
Results
After excluding all duplicates, the total number of docu-
ments retrieved by our search on multiple electronic
databases was 260. Six additional articles potentially eli-
gible were identified through hand-searches. Of these
266 records, 251 documents were excluded by their titles
and abstracts. Most epidemiologic studies found by the
search in electronic databases investigated whether pa-
ternal and/or maternal exposure to multiple pesticides
(including GLY) was associated with a higher risk of
decreased fecundity, miscarriages and congenital malfor-
mations and/or functional disorders in the progeny.
Only the studies testing whether GLY-based herbicides
were associated with altered fecundity and/or adverse
pregnancy outcomes were eligible for review. As shown
in the flowchart depicted in Fig. 1, 3 out of 15 full-text
articles assessed for eligibility were excluded and the rea-
sons for their ineligibility are informed in Table 1. Seven
out of the 12 remaining studies addressed the question
as to whether parental exposures to GLY increased risks
of birth defects and/or childhood functional disorders in
the offspring (Table 2), while the other five studies inves-
tigated potential effects of exposure to this herbicide on
time-to-pregnancy, pre-term deliveries, small-for-
gestational-age births and pregnancy losses (Table 3).
Birth defects and childhood diseases in the progeny
A case–control study by Garcia et al. [13] investigated
whether father exposure to pesticides increased the risk
of birth defects. Garcia et al’s study considered only con-
genital anomalies or groups of defects with a high preva-
lence at birth. Controls were non-malformed live-born
babies matched (1:1) with the cases by hospital and date
of birth. Individual exposures were assessed by inter-
viewing (questionnaire) fathers and mothers for involve-
ment in activities potentially related to pesticide
exposure. The risk period for exposure was defined as
3 months before conception or during the 1st trimester
or both for the father and during the 1st month preced-
ing conception and the 1st trimester or both for the
mother. Risk estimates were calculated for all birth de-
fects jointly. Dichotomous (exposed/ not exposed) data
analysis revealed a positive association between exposure
to pyridil derivatives and malformations (adjusted OR,
95 % CI, 2.77, 1.19-6.44), whereas no association be-
tween GLY (0.94, 0.37-2.34) and other pesticides with
congenital anomalies was detected.
Rull et al. [14] pooled data from two case–control
study populations of infants with Neural Tube Closure
Defects (NTD) and non-malformed controls (California,
US, 1987–1991) to investigate whether maternal
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Publications identified through the 
search on electronic databases * 
after exclusion of duplicates  
(n=260)
Records screened through their
titles and abstracts (n = 266)
Records excluded (n =  251):
53   Non mammalian species studies 
6     In vitro and ex vivo studies
9 Rodent studies 
21 Agronomic studies 
25 Letters, review articles, book chapters,  
editorials 
3 Documents issued by WHO / FAO, NTP
134 Outcomes and exposures not related to  
reproduction and/or in utero development
Full-text articles assessed for 
eligibility (n = 15)
Full-text articles not eligible 
(n = 3)
Studies  included in the 


































Publications identified through 
hand searches (n=6)
Fig. 1 Flowchart of selection of observational studies for inclusion in the systematic review. *MEDLINE, TOXLINE, Bireme/BVS and SCOPUS
Table 1 Characteristics of excluded studies (full text articles) and the reason for their ineligibility
Study Study type, population and
location
Exposure assessment Conclusions Reason for ineligibility
Pogoda and Preston-
Martin, 1997. [35]
Follow up to population-
based case–control study of
pediatric brain tumors in Los
Angeles county, CA, US, from
1984 through June 1991.
Cases, N = 224, Controls,
N = 218.
Household pesticide use
from pregnancy to diagnosis
assessed by phone
interviews.
Risk was elevated for flea-tick
pesticides, OR = 1.7, 1.1-2.6.
Round up was listed among
pesticides (herbicides) used
in law-garden. However, only
associations between broad
classes of pesticides and the
outcome (brain tumors) were
tested. Exposure assessment
encompassed both pre and
postnatal development and
did not discriminate between
the two periods.
Larsen et al., 1998. [36] Retrospective study of time-
to-pregnancy (fecundability)
among Danish farmers (N =
1146). Telephone interviews
on time-to-pregnancy (How
many months did it take
your wife to get pregnant?)
and reproductive history
Exposure data obtained by
phone interviews (use of
pesticides the year before
the youngest child was
born). Exposed groups:
traditional farmers, traditional








Although GLY is mentioned
in the Introduction section,
authors did not investigate
whether ‘time-to-pregnancy”
was altered specifically by
this herbicide. The authors
tested only classes of
“pesticides”.
Nevison 2014. [37] Ecological-type study design.
Temporal trends (1970–2005)
in autism compared to
temporal trends in US
application of GLY. Autism
counts were from the
Individuals with Disabilities
Education Act (IDEA)
database for 50 US states
plus District of Columbia.
GLY exposure data were
aggregated at the group
level. Data were from US
department of agriculture.
Increasing trends in
application of GLY positively
correlated to a marked rise in
autism prevalence in the US.
In this study of temporal
trends, data on potential
exposure were aggregated at
the whole US population
level and encompasses
preconception, pre-natal and
postnatal periods of develop-
ment. Moreover, the eco-
logical study design leaves
the door wide open for non-
causal explanations for the
observed parallel rise in
temporal trends in GLY use
and autism prevalence.
GLY glyphosate
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Table 2 Studies of parental exposures to glyphosate and birth defects or functional disorders in the progeny
Study Study type, population and
location
Exposure assessment Adverse pregnancy outcome Association with GLY –
Statistical Analysis OR (CI 95 %)
Garcia et al.,
1998 [13]
Case–control study with 261
matched pairs in 8 hospitals of
Comunidad Valenciana, Spain.
Paternal exposure. Fathers were
interviewed for obtaining
detailed information on direct
involvement in handling of
pesticides.
Congenial malformation (any) 1.23 (0.59-2.56) crude
0.94 (0.37-2.34) adjusted






1991 (pooled data of 2 case–
control studies)b. Controls:
unmatched randomly sampled
from all live born in the same
sampling time without
congenital anomalies
diagnosed before the 1st
birthday.
Maternal residential proximity
(<1,000 m) to pesticide sprayed
crops during early pregnancy
/questionnaire (residential
addresses 2 weeks or more
during the periconceptional
period linked to geographic








Case–control study. CA Birth
Defects Monitoring Program,
1997–2006. San Joaquin Valley
CA US. Cases (n = 763): infants/
fetuses with anencephaly or
spina bifida and those with
cleft palate (CP) or cleft lip (CL)
with or without CP. Diagnoses
confirmed by clinical
geneticists. Cases suspected to
having singe-gene conditions,
chromosome abnormalities
and an identified syndrome
were not eligible. Controls (n =
974) non-malformed live-born
infants selected at random
from birth hospitals.
Maternal residential proximity
to pesticide sprayed crops
during periconceptional period
(time window of exposure:
1 month before to
2 monthsnths after reported
date of conception) (computer-
based questionnaire
administered primarily by
telephone 6 weeks to
24 months after the date of
infant delivery). Mothers with
diabetes were excluded.
NTD, orofacial clefts 0.9 (0.5-1.9) – anencephaly
0.9 (0.5-1.4) – spina bifida
0.9 (0.7-1.3) - CL w/wo CP




population was all male infants
born from 1991–2004 to
mothers who were residents of
8 CA Central Valley counties.
Cases (n = 690) were infants
with hypospadias ascertained
by the CA Birth Defects
Monitoring Program (1991–
2004); Controls (n = 2195) were
live-born male infants with no
major malformation selected
randomly from the birth
population (n = 2195).
Maternal residential proximity
(within a 500 m radius) to
pesticide sprayed crops during
early pregnancy (1–98 days




numbers were used to request
access to maternal residential
addresses at delivery. Data on
pesticide applications (Pesticide
Use Reporting records) were
from the CA department of
pesticide regulation.
Hypospadias 0.68 (0.34-1.37) – lowest (total
amount applied <1.22 lb)
0.44 (0.19-1.01) – intermediate
(total-amount applied
1.22-6.92 lb).
0.88 (0.48-1.64) – highest (total




population was from the San
Joaquim Valley of California, US
(1997–2006). Cases were 156
infants/fetuses were infants
with gastroschisis confirmed by
clinical geneticists and the
controls (n = 785) were non-
malformed live-born infants
randomly selected from birth
hospitals to represent the
population from which the
cases arose. Cases with
recognized or suspected to
have single-gene conditions or
chromosomal abnormalities or
Residential proximity (within
500 m radius) to pesticide
applications (to estimate
pesticide applications data
were obtained from Pesticide
Reporting Records from the
California Dept of Pesticide
Regulation). Maternal
interviews (by phone) using a
standardized computer-based
questionnaire took place
between 6 weeks and
24 months after infant’s
estimated date of delivery.
Mothers reported residential
history from 3 month before
Gastroschisis 0.9 (0.6-1.4) – crude OR
0.9 (0.6-1.5) – adjusted OR
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residential proximity (within 1000 m) to pesticide appli-
cation areas during early pregnancy would increase the
risk of these birth defects. Results revealed a significant
association between residential proximity to GLY appli-
cation sites and NTD in the offspring when a single-
pesticide model of conventional logistic regression
analysis was used (OR = 1.5; 1.0-2.4). The association of
GLY with NTD, however, was not significant when a
multiple-pesticide model was adopted in the logistic re-
gression analysis (OR = 1.5; 0.8-2.9).
Carmichael et al. [15] conducted a case–control study
to evaluate whether maternal residential proximity
Table 2 Studies of parental exposures to glyphosate and birth defects or functional disorders in the progeny (Continued)
with identifiable syndromes
were ineligible. Cases and
controls whose mothers had
diabetes were excluded from
analysis.
conception through delivery,
including dates and residences
occupied for >1 month. Time
window of exposure analyzed
went from 1 month before to
2 months after the mother





between 1991 and 1996) in
Red River Valley, Minnesota US.
Participants randomly selected
were invited by phone
interview and asked to return a
detailed written questionnaire
on reproductive health and
pesticide use assessment.
Informants were at least one
member of 695 families (228
male spouse applicators, 90
female spouses, 377 couples).
Each certified pesticide
applicator was interviewed by
phone on current and past use
of pesticides with attention to
product name, years used and
no. of days per year applied.
Approximately 6 months later
participants were interviewed
again by a written
questionnaire. Spouses were
also interviewed by phone and
again by written questionnaire.
Frequencies of the outcome
were compared between those
who reported the use of GLY







couples were from the Ontario
Farm Family Health Study
(OFFHS), a study designed to
retrospectively assess the
effects of pesticide exposures
on reproductive health.
Couples were eligible if they
were married or living as
married, living year-around on
a farm operation, and the wife
was at most 44 years of age.
Questionnaire were mailed to
each farm family to get
information on health status,
pesticide use and farm-activity
exposures. Farm wives were
asked to self-report if “the
doctor has ever told them” if
their child had had chronic
bronchitis or cough, asthma,
hayfever or allergies.
Information on agricultural
chemicals used on the farm 6
largest crops sown or
harvested in 1991 were
obtained through a
questionnaire addressed to the
farm operator. Information on
historical farm chemical used
was obtained by questionnaire.
Questionnaires addressed to
husband and wife asked
information pertaining to
chemical activities on the farm
and around the home. The
year and month of chemical
use was matched with months
and years leading up to and of
each pregnancy. Pesticide
exposures during the
pregnancy period (month of
conception until the month of
delivery) were considered in
the analysis of child health
outcomes. Unexposed
pregnancies were those with
no reported pesticide use
during the same period.
Analysis: ratios exposed cases
to total exposed to GLY.
Persistent cough / bronchitis,
asthma, allergies






GLY glyphosate, SGA Small for Gestational Age, CL cleft lip, CP cleft palate, NTD neural tube defect, TTP (Time-to-pregnancy) is defined as the duration that a
couple waits from initiating attempts to conceive until conception occurs. TTP is used to calculate probability of conception or the fecundability odds ratio (fOR).
NTD a including elective termination of pregnancy, confirmed diagnosis of anencephaly, spina bifida cystica, craniorrhachischisis and iniencephaly. First study:
children of women in most CA counties, Second study: all CA counties except LA, Ventura and Riverside. ADD/ADHD Attention Deficit Disorder/Attention Deficit
Hyperactivity Disorder. Significant associations are highlighted marked in bold type
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Table 3 Studies of parental exposures to glyphosate and reproductive outcomes other than birth defects




Association with GLY – Statistical
Analysis OR (CI 95 %) / CFRa
Savitz et al., 1997
[20]
Retrospective cohort study.
Ontario Farm Family Health Study
(OFFHS), farms likely to be full-
time family-run operations were
selected based on 1986 Canadian
Census of Agriculture. Couples
were considered as eligible
(telephone interview) based on
residence on or near the farm-
year-round, and age of female
partner (≤44 years old). Among
1898 farm couples with
completed questionnaires (from
farm operator, husband and wife),
3984 pregnancies were identified.
Paternal exposure assessed by
questionnaire interview. Men
were asked about their farm
activities over the past 5 years.
Five activities were presumed to
involve direct pesticide exposure:
mixing or applying crop
herbicides, insecticides, and
fungicides, yard herbicides,
livestock chemicals and building
pesticides. Male partners engaged
in any activity associated with
direct pesticide exposure for
≥1 month in the time window of
3 months before conception to
the time of conception.
Abortion 1.5 (0.8-2.7) – adjusted– abortion
(crop)




0.8 (0.2-2.3)–adjusted- SGA- (crop)Pre-term delivery
SGA births
Curtis et al., 1999
[21]
Retrospective cohort study.
OFFHS – same as described
above. Only planned pregnancies
were selected for the analysis
regardless of the pregnancy
outcome.
Paternal exposure assessed by
questionnaire interview. Pesticide
used on the farm (monthly use)
during the month trying to
conceive or at any time during
the prior 2 months to capture the
time dependent exposure interval
that may have affected
spermatogenesis (64 days).
Fecundability GLY exposure / CFRa : adjusted
Woman activity regardless man
activity - 0.61 (0.30-1.26)
Man activity / no woman activity
1.30 (1.07 – 1.56)
(↑fecundability) Farm pesticide
use/no couple activity
1.26(0.94-1.69) No pesticide use/





OFFHS – same as described
above
Paternal exposure assessed by
questionnaire interview. Male
farm activities in the period from
3 months prior to conception
through the month of
conception were assessed by
questionnaire and evaluated in
relation to miscarriages, pre-term
delivery and SGA births.
Abortion 1.7 (1.0-2.9)–pre-conceptional
exposure and late abortion (12–
19 weeks) 1.1 (0.7-1.9) – pre-
conceptional exposure and early
abortion (<12 weeks) 1.1 (0.7-1.7)
– post-conceptional exposure and
abortion at any gestational age.
Sanin et al., 2009
[23]
Ecological-type study design.
2004–2005 Outcome was time to
pregnancy evaluated by
questionnaire interview (How
many months have you having
sexual intercourse before you
became pregnant for the first
time?) women were invited to
participate if their first pregnancy
during the last 5 years and did
not take contraceptives the year
before becoming pregnant. 2751
women were included in the
analysis. 159 women who
reported consultation with a
physician for fertility problems
were excluded from multiple
regression and alternative models.
Exposure measurement: Five
regions of Colombia with
different agricultural practices and
presence or not of aerial spray for
eradication of illicit crops with
GLY
Time-to-pregnancy Aerial spraying of GLY was not
consistently associated with a
delayed time to pregnancy.
Sathyanarayana
et al. 2010 [24]
Multiple regression analysis of
birth weight. Pesticide applicators
and their spouses enrolled
between 1993 and 1997, Iowa
and North Caroline US.
(2246 women).
Exposure assessed by interview
and questionnaire
Birth weight Mean birth weight ± SD: 3586 ±
546 g.
GLY-associated change in birth
weight: 4 g, −40 to + 48 g. (NS)
CFRa Conditional fecundability ratio, NS non-significant, GLY glyphosate, SGA small for the gestational age. Significant associations are highlighted in bold type.
↑fecundability = increase in fecundability
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(within 500 m radius) to agricultural pesticide applica-
tion areas during early pregnancy (i.e., 1–14 weeks of
embryonic age or 1–98 days of date of conception) was
associated with an increased incidence of hypospadias in
the offspring (data collected by the investigators refer to
births occurring from 1991 to 2004 in 8 counties in CA,
US). Carmichael et al’s study found no association of
most pesticides including GLY with increased risks of
hypospadias (phosphonoglycine, highest dose group: OR
= 0.88, 0.48-1.64).
Yang et al. [16] investigated whether maternal expos-
ure to pesticides (including GLY) during periconcep-
tional period (i.e., from 1 month before to 2 months
after the estimated date of conception) increases the
risks of NTDs and/or orofacial clefts in the progeny.
Maternal exposure to pesticides was inferred from the
residential proximity to sprayed crops assessed by a
questionnaire. Case–control analysis (based on data
from the US National Birth Defects Prevention Study,
from 1997 to 2002) found no association between GLY
(phosphonoglycine) and anencephaly (OR = 0.9, 0.5-1.9),
spina bifida (OR = 0.9, 0.5-1.4), cleft lip with and without
cleft palate (OR = 0.9, 0.7-1.3) and cleft palate alone (OR
= 0.9, 0.5-1.5).
Shaw et al. [17] conducted a case control study in a
population derived from one of the regions of highest
use of pesticide in the US (San Joaquin Valley – CA) to
examine whether early gestational exposures to pesti-
cides (including GLY) were associated with risk of gas-
troschisis. Exposure during early gestation was assessed
by residential proximity (within 500 m radius) to GLY/
pesticide applications from one month before to
2 months after mother reported date of conception. The
investigators found no association between gastroschisis
and maternal exposure to GLY (adjusted OR = 0.9 (0.6-
1.5).
In addition to the foregoing studies on GLY and con-
genital malformations, three other studies investigated
associations of prenatal exposures to GLY with postnatal
functional disorders in the exposed offspring.
A cross-sectional study by Garry et al. [18] conducted
in 1997–1998 examined the incidence of birth defects
and sex ratios in children born to pesticide applicators
(695 families) living in the Red River Valley of Minne-
sota, US. The investigators employed a detailed ques-
tionnaire to assess parental exposure to pesticides and
examined medical records and birth certificates to con-
firm parent-reported health information. Of 19 children
with Attention Deficit Hyperactivity Disorder (ADD/
ADHD), 5 were excluded from the analysis because the
male applicator was reported as not being the biological
father. The investigators found that 6 out of the
remaining 14 children (43 %) who had parent-reported
ADD/ADHD were born to GLY or phosphonamine
herbicide applicators (OR = 3.6, 95 %-CI, 1.35-9.65).
Weselak et al [19] used data from the Ontario Farm
Family Health Study (OFFHS) to investigate whether ex-
posure of farm couples to pesticides (including GLY)
during pregnancy increases the risk of health problems
in their offspring, including persistent cough or bron-
chitis, asthma, and allergies or hay fever. The authors
found no association between GLY exposure during
pregnancy and persistent cough or bronchitis (male and
female offspring combined, adjusted OR, CI 95 %, 0.71,
0.21-2.35), asthma (0.82, 0.35-1.90), and hay fever and
allergies (0.98, 0.46-2.10).
In summary, except for positive associations of paren-
tal exposure to GLY with ADD/ADHD [18] and NTD
(single-pesticide model of logistic regression) [14], we
found no other evidence suggesting that parental expos-
ure to GLY before conception and/or during pregnancy
increases the risk of birth defects and/or psychiatric or
immune system disorders in the progeny.
Miscarriages, pre-term deliveries, small-for-gestational-
date births, and fecundability
Three retrospective cohort studies based on data from
OFFHS study were published in the late 1990s and early
2000s. The OFFHS study was designed to assess retro-
spectively the potential adverse effects of commonly
used pesticides on pregnancy (Table 3).
Savitz et al [20] examined the effects of male partner
self-reported exposure to pesticides (0 to 3 months prior
to conception) on female partner miscarriages, pre-term
deliveries and small for gestational age births (SGA).
Among 1898 farm couples with completed question-
naires, 3984 pregnancies were identified. Of the included
pregnancies, nearly 40 % occurred 10 or more years be-
fore the interview, a long time interval that possibly en-
hanced the recall bias. Adjusted OR (CI 95 %) for GLY
and miscarriages was 1.5 (0.8–2.7) and 1.4 (0.7–2.8) for
crop and yard herbicides, respectively. No significant as-
sociations were found for GLY and pre-term deliveries
(2.4, 0.8-7.9, crop), and GLY and SGA (0.8, 0.2-2.3,
crop).
A study by Curtis et al [21], including only planned
pregnancies (N = 2012), evaluated whether exposure to
Table 4 Incidence of congenital malformations in the Chaco











1997-8 46 24,030 19.1
2001-2 60 21,339 28.1
2008-9 186 21,808 85.3
aNeonatology Department, Hospital Perrando, Resistencia, Chaco Province,
Argentina. Data were from the report by the Water Pollutants Investigation
Committee, Chaco Province, Argentina, 2010 [27]
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pesticides, assessed considering farm use and individual
farm activities, was associated with a longer time-to-
pregnancy. The results indicated that the use of GLY on
the farm and pesticide activities reported by the hus-
band, but not by the wife, was associated with a slightly
increased fecundability (Conditional fecundability ratio;
CFR, CI 95 %, 1.30, 1.07-1.56). The authors found no
other significant association between GLY and altered
time-to-pregnancy. Overall, study results are consistent
with the notion that exposure to GLY in farm activities
did not impair fecundability.
A third study based on OFFHS data [22] found a sig-
nificant association (OR = 1.7, 1.0-2.9) between parental
pre-conception exposure to GLY and the risk of late
abortions (12–19 weeks). The risk of early abortions,
however, remained unaltered (<12 weeks; OR = 1.1, 0.7-
1.9) if parents were exposed to GLY prior to conception.
Post-conception exposure to GLY did not increase the
risk of abortion at any gestational age (OR = 1.1, 0.7-1.7).
A positive association between exposure to GLY before
conception and late abortions is an unusual finding. Ma-
ternal and/or paternal preconception exposures are gen-
erally associated with early abortions (e.g., due to germ
cell chromosomal abnormalities) while maternal expo-
sures during pregnancy are most often associated with
late abortions (e.g., due to harmful effects on the
conceptuses).
An ecological-type study by Sanin et al [23] examined
whether application of glyphosate by aerial spray for
eradication of illicit crops (five Colombian departments,
cross-sectional study, 2004–2005) was associated with
prolonged time-to-pregnancy among fertile women liv-
ing in sprayed areas. While data on the exposure to GLY
were aggregated at the group level and place of resi-
dence is an inaccurate surrogate for degree of exposure,
the study by Sanin et al (2009) showed no consistent as-
sociation between aerial spray of GLY and longer average
time-to-pregnancy in the population (Table 3).
Sathyanarayana et al [24] examined the association be-
tween maternal pesticide use and birth weight among
women in the Agricultural Health Study (AHS), a large
study of pesticide applicators and their spouses, enrolled
between 1993 and 1997 in Iowa and North Caroline.
The authors evaluated self-reported pesticide use of 27
active ingredients in relation to birth weight among
2246 women. Multiple regression estimates of change in
birth weight (adjusted for site, maternal BMI, age, smok-
ing, race, pre-term birth, medical parity) were obtained.
Sathyanarayana et al found no association between birth
weight and parental exposure to GLY (mean birth
weight = 3586 ± 546 g; GLY-associated change in birth
weight, 4 g; −40 to 48) (Table 3).
In summary, except for a positive association between
parental pre-conception exposure to GLY and the risk of
late abortions [22], studies included in this review re-
vealed no evidence of increased risks of miscarriages,
pre-term deliveries, small-for-gestational age births and
impaired fecundability associated with occupational ex-
posures to GLY-based herbicides before conception and/
or during pregnancy.
Reports on the occurrence of birth defects in South
America GM soybean crop areas
Antoniou et al (2012) and others [9–11] cited two stud-
ies by South American researchers [24, 25] and one re-
port from Chaco province (Argentina) health authorities
in support of their statement that regulatory agencies
have neglected the existing evidence suggesting that
GLY might increase the risk of birth defects. The two
studies were published in Spanish in South American
medical journals [25, 26], while an English version of
Chaco province report is available on the web [27]. None
of these studies were identified by our search in elec-
tronic databases.
A case–control study by Benítez-Leite et al [25] found
an increased rate of birth defects in neonates born to
women exposed to unspecified pesticides during preg-
nancy. Although the article did not mention explicitly
GLY-based herbicides, cases and controls came from a
regional hospital in Itapúa Department (Paraguay) where
GLY is extensively used in GM-soy crops. Conclusions
from Benitez-Leite et al’s investigation should be inter-
preted with caution due to study methodological weak-
nesses including 1) the lack of adequate control for
selection and/or confounding bias, i.e., cases and con-
trols were not matched according to a number of vari-
ables of interest (e.g., maternal age, use of medicines and
others), nor were logistic regression and stratification
used in the analysis of data; 2) an uncontrolled recall
bias (mothers of malformed and healthy infants are
known to remember differently past exposures); 3) the
lack of detailed information on the applied questionnaire
and on how interviewers were trained to avoid introdu-
cing an information bias (the interviewers were hospital
internal doctors and nurses who were aware of the case
or control status of the respondent); and 4) the inaccur-
ate and dichotomous (Yes/No) assessment of pesticide
exposure.
A cross-sectional study by Campaña et al. [26] re-
ported the prevalence of 27 congenital anomalies in 7
geographic regions of Argentina including Cordoba and
other provinces of intensive GM-soy planting and heavy
use of GLY. The estimated prevalence of 27 birth defects
in distinct regions was based on a sample of 21,844 mal-
formed infants selected from a total of 855,220 births in
59 Argentinean hospitals of the ECLAMC (Latin Ameri-
can Collaborative Study on Congenital Malformations)
network between 1997 and 2007. The estimated
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frequencies for 14 birth defects were higher in one or
more regions when compared to the overall incidence
for all 7 regions combined. For instance, the prevalence
of spina bifida in Cordoba (CEN region, 12.2, 10.1-14.3)
was somewhat higher than the overall prevalence in all
regions combined (TOTAL, 9.9, 9.2-10.6). It was similar,
however, to the prevalence of spina bifida in Buenos
Aires metropolitan region (MET, 13.2, 11.8-14.7). The
prevalence of anencephaly in Cordoba (CEN, 7.9, 6.3-
9.8), on the other side, was similar to the prevalence es-
timated for all regions combined (TOTAL, 7.5, 6.9-8.1)
and somewhat lower than the prevalence in Buenos
Aires region (MET 10.3, 9.1-11.7). Overall, differences in
the estimated prevalence of birth defects among regions
were not consistent with the interpretation that there is
an increased prevalence of NTDs and other congenital
anomalies in Cordoba and/or in other regions of exten-
sive use of GLY-based herbicides. It is of note that
ECLAMC is a hospital-based (and not a population
based) monitoring system, and thus regional frequencies
estimated by Campaña et al. [26] do not necessarily re-
flect the prevalence of a birth defect in the population of
the region. In addition to the foregoing, even if popula-
tion based frequencies of some anomalies vary among
regions, there exist many other possible explanations for
inter-region differences including secular trends, altitude
above sea level, folic acid fortification of wheat flour (in-
troduced in Argentina in 2005, i.e., within the time
period of study data gathering: 1997–2007), ethnicity,
maternal age (not adjusted by authors’ analysis) and a di-
versity of environmental factors and exposures.
An Investigation Committee commissioned by the
government of Chaco province (Argentina) described a
nearly three-fold increase in the incidence of birth de-
fects in the region of La Leonese-Las Palmas during the
last decade [27, 28]. Since the apparent rise in the inci-
dence of congenital anomalies paralleled a marked GM-
soy crop expansion, the extensive use of GLY in the re-
gion has emerged as a suspected determinant factor [27,
28]. To estimate regional incidence rates, the Chaco
province investigation committee divided the number of
malformed newborns recorded by a single regional hos-
pital (i.e., a hospital-based registry) by the overall num-
ber of births in the region (a population-based registry)
for a given period of time (Table 4). While the overall
number of births in the region remained fairly constant
across the time period analysed (1997–2009), the num-
ber of malformed newborns recorded by the regional
reference hospital dramatically increased in 2008/2009.
Nonetheless, it is unclear whether the incidence of birth
defects did in fact increase in the region since a
hospital-based registry is not a reliable surrogate for a
population-based registry of birth defects. Not only a
number of births in the region may have occurred
outside the regional hospital, but also the hospital may
have received an undetermined number of pregnant
women living outside the region of interest.
In summary, the Chaco province report [27], the
case–control study by Benitez-Leite et al. [25] and the
Campaña et al. [26] descriptive study do not lend sup-
port to the interpretation that the incidence of birth de-
fects has increased in areas of extensive GM-soy
plantations and GLY application.
Discussion
As previously commented, this review included only
studies that provided results specific for GLY exposure
and reproductive and developmental outcomes, that is,
studies analyzing only whole classes of compounds such
as pesticides and herbicides or other broad categories of
active ingredients were ineligible for inclusion in the
review.
This systematic review identified 7 observational stud-
ies addressing the question of whether pre-conception
(paternal and/or maternal) and/or pregnancy (maternal)
exposures to GLY increase risks of birth defects and/or
childhood functional disorders in the offspring (Table 2).
Moreover, we also reviewed 5 studies evaluating whether
parental exposures to GLY increased risks of miscar-
riages, pre-term deliveries, SGA births and prolonged
time-to-pregnancy (Table 3). None of the studies found
significant associations of parental exposures to GLY
with unspecified congenital malformations [13] or with
specific birth defects such as gastrochisis [17], oral clefts
[16] and hypospadias [15]. One study found a positive
association of maternal residential proximity to GLY ap-
plication sites with NTDs (with a single-pesticide model
but not with a multiple pesticides logistic regression
model) [14] while a further study [16] revealed no sig-
nificant association of maternal exposure to GLY with
NTDs. No positive associations of parental exposures to
GLY with childhood allergies, asthma and bronchitis
[19], longer time-to-pregnancy [21, 23], SGA births [20,
24], and pre-term deliveries [20] were reported either.
Except for a significant association of pre-conceptional
exposure to GLY with late abortions [22], no association
of exposure to GLY with gestation losses was found [20,
22]. Overall, except for an excess of risk of ADD/ADHD
among the offspring of GLY applicators reported by
Garry et al. [18], analytical observational studies
reviewed here led to the conclusion that exposures to
GLY before conception and/or during pregnancy did not
increase the risk of adverse reproductive outcomes.
The lack of association between maternal residential
proximity to GLY-spraying areas and NTDs reported by
Rull et al (with multiple pesticides logistic regression
model) [14] and by Yang et al [16] is not consistent with
Carrasco and others’ hypothesis [4, 7] that events taking
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place during cephalic neural crest development would
be the primary target for a putative GLY developmental
toxicity. Paganelli et al’s data [4] were obtained on frog
and chicken embryos directed exposed to GLY-based
herbicides and, as far as the authors are aware, no devel-
opmental toxicity study on mammalian species (rodents
and lagomorph) has found an increased occurrence of
NTDs in GLY exposed fetuses [1].
A major limitation common to all the foregoing stud-
ies was an inaccurate assessment of the exposure. In
most studies shown in Tables 2 and 3 exposure to the
herbicide was analyzed as a dichotomous (exposed / not
exposed) variable, and the individual exposure status
was inferred from responses to interviews and question-
naires. In one study (Table 3), an ecological-type design
was used [23] and thus exposure data was aggregated at
the group level as if all individuals living in the studied
regions were evenly “exposed” or “not exposed” to GLY.
In fact, the individual exposure to GLY or any other
pesticide depends on a number of factors such as wear-
ing protective clothes, the diet, the amount of the pesti-
cide used and others and varies within a population. The
exposure or the internal dose received by members of a
population is also a continuous variable. The dichotomi-
zation of this variable is likely to make analytical studies
less sensitive to detect detrimental effects of GLY on
health outcomes, if they do occur. For example, a num-
ber of individuals assigned to the “exposed group” might
have received internal doses of GLY at levels below those
(threshold) levels that would lead to adverse outcomes
thereby diminishing the power of the study. Moreover,
treating exposure as a binary variable precludes a further
analysis of dose (concentration) – response relationship
when a significant association is eventually found. As
highlighted by Hill, a “biological gradient” or a “dose/
concentration-response relationship” is one of the as-
pects to be considered for ruling out possible non-causal
explanations for the association [29].
In 4 out of 6 studies evaluating associations between
exposure to GLY and the occurrence of birth defects or
childhood functional disorders (Table 1), maternal “resi-
dential proximity” to GLY sprayed areas was used as a
surrogate indicator of exposure to GLY. As far as the au-
thors are aware, no bio-monitoring study has investi-
gated the extent to which “residential proximity” is a
valid and reliable non-quantitative indicator of increased
exposure to GLY.
There exist only a few bio-monitoring studies on the
human exposure to GLY. A bio-monitoring study by
Acquavella et al [30] measured the levels of GLY in the
24-h urine samples of 48 farmers, their spouses and chil-
dren, as part of the Farm Family Exposure Study in Min-
nesota US. Sixty percent of farmers, 4 % of their spouses
and 12 % of their children had detectable levels of GLY
in the urine on the day of pesticide application (geomet-
ric mean concentration was 3 ppb and the maximum
value was 233 ppb). The authors noted that farmers who
did not use rubber gloves had urinary levels of GLY
higher than the levels found among those who used this
protective equipment (10 ppb versus 3 ppb). They also
observed that all but one child with detectable levels of
GLY had helped with the application or were present
during pesticide mixing, loading or application [30].
A further study by Curwin et al [31] measured urinary
levels of GLY and some other pesticides in farm and
non-farm households (47 fathers, 48 mothers and 117
children) living in Iowa (US). Curwin et al’s data demon-
strated that detectable levels of GLY are present in the
urine of most (>60 %) farm and non-farm US partici-
pants [31]. Moreover, detectable levels of GLY have also
been found in the urine of farm and non-farm European
residents by other bio-monitoring studies [32].
Two more studies published in scientific journals and
three unpublished investigations reviewed by Niemann
et al [32] also detected GLY in human urine samples.
Taken together the seven bio-monitoring studies indi-
cated that amounts of GLY in the ppb (μg/L) range are
found in the urine of farm and non-farm individuals in
the US and in the EU.
In addition to the foregoing studies on the levels of
GLY in urine samples, there is a single study on the
blood levels of GLY in pregnant women. Aris and
Leblanc [33] measured concentrations of GLY in the
blood serum of pregnant (maternal and fetal cord blood)
and non-pregnant women from Eastern towns of Que-
bec, Canada. Participants reported not to have had any
direct contact with pesticides and thus the diet remained
as the most likely origin of GLY found in their blood.
GLY was undetectable (<15 ng/mL) in the maternal and
fetal cord blood (n = 30), and detected in only 2 out of
39 (5 %) non-pregnant women.
As aforementioned, bio-monitoring studies showed
that GLY is detectable in the urine of farm and non-
farm individuals. Since soybeans and a variety of other
food items may contain trace amounts of GLY, the diet
is one of the possible sources of GLY residues found in
the urine of farm and non-farm individuals. Occupa-
tional exposure through dermal route adds to this back-
ground ingestion of GLY residues.
According to Williams et al [1] estimates of exposure
for aggregated acute and chronic exposure scenarios
based on worst-case assumptions were 125 and 32.3 μg/
kg bw/day, respectively. For young children the esti-
mated values were 97 and 52 μg/kg bw/day for acute
and chronic exposures, respectively [1]. Based on the
worst case assumptions, for an adult female applicator
estimated dietary exposure would account for 23.8 μg/kg
bw/day while occupational exposure would account for
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56.2 (acute) and 8.5 μg//kg bw/day (chronic) exposures.
For children aged 1 to 6 years, dietary exposure would
account for 51.9 μg/kg bw/d while reentry and bystander
exposures and some infrequent events would account
for the additional exposure [1]. It is of note that for oc-
cupational exposure of applicators, according to Wil-
liams et al [1], the highest measured value from all
biomonitoring studies was used for the “worst case” esti-
mation of acute exposure. Since as a rule the monitoring
studies were conducted on developed countries, the
question arises as to whether the highest estimated
values could be even higher in developing country sce-
narios where farmers do not routinely wear protective
clothes and equipment.
Acquavella et al’s study [31], for instance, demon-
strated that, among farmers, the highest urinary levels of
GLY were recorded on the day of application, and when
protective gloves were not used during mixing, loading
or spraying the herbicide. According to the authors, only
5 % of farmers’ spouses and 12 % of their children had
detectable levels of GLY in the urine, and all but one of
the contaminated children had reported a direct contact
with the herbicide product [31]. These findings raise
doubts whether a mere residential proximity to culti-
vated areas does in fact add significantly to the back-
ground exposure to GLY that occurs through the diet
irrespective of the individual place of residence.
Conclusions
In summary, except for a possible association with At-
tention Deficit Hyperactivity Disorder needing confirm-
ation by further studies – data from existing
epidemiologic studies do not lend support to the notion
that GLY is a human reproductive and developmental
toxicant. Nonetheless, this set of predominantly negative
findings is far from providing a definitive evidence that
occupational exposure to GLY poses no risk for human
development and reproductive health. This systematic
review found only a few studies on people occupationally
exposed to GLY and, as a rule, the existing studies used
non-quantitative estimations of exposure. Moreover, in-
vestigations on the potential adverse effects of GLY iden-
tified in the systematic review are heterogeneous
regarding the developmental and reproductive outcomes
studied. The variability in the outcomes investigated
(e.g., one study on hypospadias, gastroschisis, and oral
clefts, and two studies on NTDs) limits the evaluation of
the consistency of specific negative findings across epi-
demiologic studies. Finally, there is no analytical obser-
vational study conducted on developing countries where
farmers are exposed or likely to be exposed to higher in-
ternal doses of GLY because in tropical regions not to
use routinely protective clothes and equipment when
mixing, loading and spraying pesticides is the rule rather
than an exception [34]. Along this line, human risk as-
sessment would greatly benefit from a set of good qual-
ity epidemiologic studies, particularly from prospective
cohort studies with quantitative estimations of exposure
(e.g. by measuring urinary levels of GLY) before pre-
conception and during pregnancy.
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